Please provide your email address to receive an email when new articles are posted on . The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer ...
Lupin is offering Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic obstructive pulmonary disease. Tiotropium Bromide Inhalation Powder, 18 mcg/capsule is a generic ...
Backed by phase 3 INHALE-1 data, the expanded indication provides a noninvasive, needle-free mealtime insulin alternative for children and adolescents.
AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results